Medpace Holdings (MEDP) Payables (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Payables came in at $37.5 million in Q2 2026, down 13.28% on a YoY basis from $43.3 million in Q2 2025, and up 9.0% quarter-over-quarter from $34.4 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Payables (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Payables for 12 consecutive years, with $37.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Payables fell 13.28% year-over-year to $37.5 million; the trailing twelve-month figure through Jun 2026 stood at $37.5 million (down 13.28% YoY), and the FY2025 full-year result was $28.1 million, down 13.48% from the prior year.
- Payables grew to $37.5 million in Q2 2026 per MEDP's latest filing, from $34.4 million in the prior quarter.
- Across five years, Payables topped out at $278.5 million in Q2 2022 and bottomed at $24.4 million in Q1 2024.
- Historically, Payables has averaged $66.6 million across 5 years, with a median of $33.5 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Payables soared 1093.95% in 2022, then plunged 83.96% in 2024.
- Over 5 years, Payables stood at $83.1 million in 2022, then slumped by 61.64% to $31.9 million in 2023, then gained by 2.07% to $32.5 million in 2024, then dropped by 13.48% to $28.1 million in 2025, then jumped by 33.35% to $37.5 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $37.5 million, $34.4 million, and $28.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 37.53 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 118.24 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 140.98 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 54.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 57.10 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 9.58 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 5.63 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 3.90 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 621,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.53 Mn |
| Mar 31, 2026 | 34.43 Mn |
| Dec 31, 2025 | 28.14 Mn |
| Sep 30, 2025 | 26.52 Mn |
| Jun 30, 2025 | 43.28 Mn |
| Mar 31, 2025 | 61.32 Mn |
| Dec 31, 2024 | 32.53 Mn |
| Sep 30, 2024 | 26.20 Mn |
| Jun 30, 2024 | 27.39 Mn |
| Mar 31, 2024 | 24.40 Mn |
| Dec 31, 2023 | 31.87 Mn |
| Sep 30, 2023 | 29.02 Mn |
| Jun 30, 2023 | 88.61 Mn |
| Mar 31, 2023 | 152.11 Mn |
| Dec 31, 2022 | 83.07 Mn |
| Sep 30, 2022 | 167.95 Mn |
| Jun 30, 2022 | 278.50 Mn |
| Mar 31, 2022 | 25.43 Mn |
| Dec 31, 2021 | 25.68 Mn |
| Sep 30, 2021 | 25.05 Mn |